<?xml version="1.0" encoding="UTF-8"?>
<p id="par0165">In vitro studies have demonstrated CQ efficacy against SARS-CoV-2 [
 <xref rid="bib0275" ref-type="bibr">55</xref>]. With its known safety profile, clinical investigations have been held in different countries; and at least 18 trials evaluating HCQ or CQ are currently underway worldwide [
 <xref rid="bib0190" ref-type="bibr">38</xref>,
 <xref rid="bib0290" ref-type="bibr">58</xref>].
</p>
